Seth Wander, M.D., Ph.D.

Physician Investigator (Cl)
Cancer Center, Mass General Research Institute
Assistant Professor of Medicine
Harvard Medical School
Assistant In Medicine
Hematology-Oncology, Massachusetts General Hospital
MDPhD University of Miami School of Medicine 2013
cyclin-dependent kinase inhibitor p27; molecular targeted therapy; neoplasms; phosphatidylinositol 3-kinases; pyridones; signal transduction; tor serine-threonine kinases